Oscar Health (OSCR) Common Equity (2020 - 2026)

Oscar Health (OSCR) has reported Common Equity for 7 consecutive years, with $2.1 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 76.96% year-over-year to $2.1 billion; the trailing twelve-month figure through Jun 2026 stood at $2.1 billion (up 76.96% YoY), and the FY2025 full-year result was $980.7 million, down 3.51% from the prior year.
• Common Equity rose to $2.1 billion in Q2 2026 per OSCR's latest filing, from $1.7 billion in the prior quarter.
• Across five years, Common Equity topped out at $2.1 billion in Q2 2026 and bottomed at $806.1 million in Q4 2023.
• Historically, Common Equity has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2022.
• The sharpest annual moves came in 2022 and 2026: Common Equity sank 35.91% in 2022, then jumped 76.96% in 2026.
• Over 5 years, Common Equity stood at $892.4 million in 2022, then slipped by 9.67% to $806.1 million in 2023, then rose by 26.09% to $1.0 billion in 2024, then fell by 3.51% to $980.7 million in 2025, then soared by 109.55% to $2.1 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $2.1 billion, $1.7 billion, and $980.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.